Russia’s first batch of 'pure' lutetium isotopes for anti-cancer therapy obtained in TPU

TPU scientists succeeded to solve the most difficult problem and obtain ‘pure’ lutetium-177 without harmful impurities.
29 August

IT, pharmaceuticals and industrial robotics to unite TPU and Shijiazhuang Hi-Tech Industrial Development Zone

The city administration of Shijiazhuang and TPU signed an agreement on cooperation.
19 June 2018

A more affordable drug for neuroendocrine tumors diagnostics passing preclinical tests

A radiopharmaceutical based on technetium will pass preclinical tests by the end of 2018, reported by TPU scientists at the press conference.
07 May 2018

Advanced isotopic technologies discussed at TPU

Over 300 of young researchers and students, as well as experts in the field of nuclear physics from various cities and countries came to Tomsk Polytechnic University to the international conference &l...
02 November 2017

TPU commissioned a unique production of orthophosphoric acid based on phosphorus-32

Tomsk Polytechnic University began commercial supply of orthophosphoric acid based on phosphorus-32 isotope, which is used for biochemical study, diagnostics and therapy of cancer diseases. A producti...
01 November 2017

50 years of TPU research nuclear reactor

Last week the leading nuclear scientists of Russia gathered in Tomsk to celebrate the anniversary of the research reactor of Tomsk Polytechnic University. As part of the celebration the university hos...
25 September 2017

Preclinical trials of radiopharmaceutical for cancer diagnosis

A radiopharmaceutical for advanced identification of cancer, labeled with the technetium-99 isotope, is ready for the preclinical-phase trial. Scientists from Tomsk Polytechnic University, Tomsk Resea...
26 May 2017